Search research articles
Contact Us
Filters
Showing results (131-140 of 251) with videos related to
Page
of 26
Sort By:
Leukemia
|
July 30, 2003
Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes
A List, M Beran, J DiPersio, et al.
Leukemia
|
October 27, 1997
Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia
S O'Brien, H Kantarjian, M Beran, et al.
Leukemia
|
February 3, 1998
Cellular pharmacology of mitoxantrone in p-glycoprotein-positive and -negative human myeloid leukemic cell lines
U Consoli, N T Van, N Neamati, et al.
Blood
|
January 1, 1981
Adherent cell inhibition of human leukemic in vitro agar clonal growth by short-term cell-to-cell contact
G Spitzer, D S Verma, M Beran, et al.
Cancer Research
|
February 15, 1987
In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia
B S Andersson, M Beran, M Bakic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2001
Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells
B Scappini, F Onida, H M Kantarjian, et al.
Folia Microbiologica
|
January 1, 1991
Macrotetrolide antibiotics produced by Streptomyces globisporus
J Jizba, P Sedmera, J Zima, et al.
Blood
|
August 15, 1995
Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy
S O'Brien, H Kantarjian, M Beran, et al.
Experimental Hematology
|
August 1, 1980
Colony stimulating factor augmentation in human placental conditioned medium
D S Verma, G Spitzer, M Beran, et al.
Leukemia & Lymphoma
|
January 1, 1993
Nucleoside analogs in treatment of chronic lymphocytic leukemia
M J Keating, S O'Brien, H Kantarjian, et al.
Page
of 26
Search research articles
Search
Showing results (131-140 of 251) with videos related to
Sort By:
Page
of 26
Leukemia
|
July 30, 2003
Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes
A List, M Beran, J DiPersio, et al.
Leukemia
|
October 27, 1997
Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia
S O'Brien, H Kantarjian, M Beran, et al.
Leukemia
|
February 3, 1998
Cellular pharmacology of mitoxantrone in p-glycoprotein-positive and -negative human myeloid leukemic cell lines
U Consoli, N T Van, N Neamati, et al.
Blood
|
January 1, 1981
Adherent cell inhibition of human leukemic in vitro agar clonal growth by short-term cell-to-cell contact
G Spitzer, D S Verma, M Beran, et al.
Cancer Research
|
February 15, 1987
In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia
B S Andersson, M Beran, M Bakic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2001
Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells
B Scappini, F Onida, H M Kantarjian, et al.
Folia Microbiologica
|
January 1, 1991
Macrotetrolide antibiotics produced by Streptomyces globisporus
J Jizba, P Sedmera, J Zima, et al.
Blood
|
August 15, 1995
Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy
S O'Brien, H Kantarjian, M Beran, et al.
Experimental Hematology
|
August 1, 1980
Colony stimulating factor augmentation in human placental conditioned medium
D S Verma, G Spitzer, M Beran, et al.
Leukemia & Lymphoma
|
January 1, 1993
Nucleoside analogs in treatment of chronic lymphocytic leukemia
M J Keating, S O'Brien, H Kantarjian, et al.
Page
of 26